Terazosin: Difference between revisions

Jump to navigation Jump to search
m (Changed protection level for "Terazosin" ([Edit=Allow only autoconfirmed users] (expires 23:38, 20 March 2014 (UTC)) [Move=Allow only autoconfirmed users] (expires 23:38, 20 March 2014 (UTC))))
No edit summary
Line 1: Line 1:
{{SI}}
__NOTOC__
{{Terazosin}}
{{CMG}}; {{AE}}


{{CMG}}
'''''For patient information about Terazosin, click [[Terazosin (patient information)|here]].'''''


{{SB}}
Terazosin HCl, Terazosin hydrochloride, Terazosina, Terazosine, Terazosinum, Trazosin HCl, Abbott 45975, Blavin, Flumarc, Fosfomic, Heitrin, Hytracin, Hytrin, Hytrinex, Itrin, Urodie, Vasocard, Vasomet, Vicard


==Overview==
'''Terazosin''' (marketed as '''Hytrin '''or''' Zayasel''') is a selective [[alpha 1 antagonist]] used for treatment of symptoms of an enlarged [[prostate]] ([[benign prostatic hyperplasia|BPH]]). It also acts to lower the [[blood pressure]], and is therefore a drug of choice for men with [[hypertension]] and prostate enlargement.
It works by blocking the action of [[adrenaline]] on [[smooth muscle]] of the [[urinary bladder|bladder]] and the [[blood vessel]] walls.
Most common side effects include dizziness, drowsiness, headache, constipation, loss of appetite, fatigue, nasal congestion or dry eyes, but they generally go away after only a few days of use. Therapy should always be started with a low dose to avoid [[first dose phenomenon]].<ref>[http://www.rxlist.com/cgi/generic/teraz_wcp.htm Hytrin (Terazosin Hcl) drug warnings and precautions - prescription drugs and medications at RxList<!-- Bot generated title -->]</ref> Sexual side effects are rare, but may include [[priapism]] or [[erectile dysfunction]].
==Category==
Alpha adrenergic blockers.
==FDA Package Insert==


==Overview==
====TERAZOSIN®===
<small>'''''Synonyms / Brand Names:''''' Terazosin HCl, Terazosin hydrochloride, Terazosina, Terazosine, Terazosinum, Trazosin HCl, Abbott 45975, Blavin, Flumarc, Fosfomic, Heitrin, Hytracin, Hytrin, Hytrinex, Itrin, Urodie, Vasocard, Vasomet, Vicard</small>
 
 
'''  [[Terazosin indications and usage|Indications and Usage]]'''
'''| [[Terazosin dosage and administration|Dosage and Administration]]'''
'''| [[Terazosin dosage forms and strengths|Dosage Forms and Strengths]]'''
'''| [[Terazosin contraindications|Contraindications]]'''
'''| [[Terazosin warnings and precautions|Warnings and Precautions]]'''
'''| [[Terazosin adverse reactions|Adverse Reactions]]'''
'''| [[Terazosin drug interactions|Drug Interactions]]'''
'''| [[Terazosin use in specific populations|Use in Specific Populations]]'''
'''| [[Terazosin overdosage|Overdosage]]'''
'''| [[Terazosin description|Description]]'''
'''| [[Terazosin clinical pharmacology|Clinical Pharmacology]]'''
'''| [[Terazosin nonclinical toxicology|Nonclinical Toxicology]]'''
'''| [[Terazosin clinical studies|Clinical Studies]]'''
'''| [[Terazosin how supplied storage and handling|How Supplied/Storage and Handling]]'''
'''| [[Terazosin patient counseling information|Patient Counseling Information]]'''
'''| [[Terazosin labels and packages|Labels and Packages]]'''


==Dosing and Administration==
==Mechanism of Action==
'''Benign prostatic hyperplasia'''
*Initial dose: 1 mg at bedtime is the starting dose for all patients, and this dose should not be exceeded as an initial dose. Patients should be closely followed during initial administration in order to minimize the risk of severe hypotensive response.
'''Hypertension'''
*Initial dose: 1 mg at bedtime is the starting dose for all patients, and this dose should not be exceeded. This initial dosing regimen should be strictly observed to minimize the potential for severe hypotensive effects.


==References==


{{FDA}}
{{Reflist|2}}


[[Category:Cardiovascular Drugs]]
[[Category:Drugs]]
[[Category:Drugs]]
{{WH}}
{{WS}}

Revision as of 04:00, 7 March 2014

Terazosin
Terazosin®, Hytrin® FDA Package Insert
Indications and Usage
Dosage and Administration
Contraindications
Warnings
Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials on Terazosin
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

For patient information about Terazosin, click here.

Synonyms / Brand Names:

Terazosin HCl, Terazosin hydrochloride, Terazosina, Terazosine, Terazosinum, Trazosin HCl, Abbott 45975, Blavin, Flumarc, Fosfomic, Heitrin, Hytracin, Hytrin, Hytrinex, Itrin, Urodie, Vasocard, Vasomet, Vicard

Overview

Terazosin (marketed as Hytrin or Zayasel) is a selective alpha 1 antagonist used for treatment of symptoms of an enlarged prostate (BPH). It also acts to lower the blood pressure, and is therefore a drug of choice for men with hypertension and prostate enlargement.

It works by blocking the action of adrenaline on smooth muscle of the bladder and the blood vessel walls.

Most common side effects include dizziness, drowsiness, headache, constipation, loss of appetite, fatigue, nasal congestion or dry eyes, but they generally go away after only a few days of use. Therapy should always be started with a low dose to avoid first dose phenomenon.[1] Sexual side effects are rare, but may include priapism or erectile dysfunction.

Category

Alpha adrenergic blockers.

FDA Package Insert

=TERAZOSIN®

Indications and Usage | Dosage and Administration | Dosage Forms and Strengths | Contraindications | Warnings and Precautions | Adverse Reactions | Drug Interactions | Use in Specific Populations | Overdosage | Description | Clinical Pharmacology | Nonclinical Toxicology | Clinical Studies | How Supplied/Storage and Handling | Patient Counseling Information | Labels and Packages

Mechanism of Action

References